ClexBio

ClexBio is a preclinical tissue therapeutics company driving a paradigm shift in modern medicine. Their VivoSet™ technology enables the creation of fully vascularized therapeutic tissues, providing a thriving cellular microenvironment to restore lost cell and organ function, permanently. They focus on addressing chronic diseases with no current effective solutions, such as Type I Diabetes, advanced liver diseases, and heart disease.